Comparative analysis of DNA repair in stem and nonstem glioma cell cultures

Molecular Cancer Research

Volumn 7, Issue 3, 2009, Pages 383-392

  Ropolo, Monica ^a   Daga, Antonio ^a   Griffero, Fabrizio ^a   Foresta, Mara ^a   Casartelli, Gianluigi ^a   Zunino, Annalisa ^a   Poggi, Alessandro ^a   Cappedi, Enrico ^b   Zona, Gianluigi ^c   Spaziante, Renato ^c   Corte, Giorgio ^a,d   Frosina, Guido ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c Section of Neurosurgery   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; HISTONE H2AX;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL CYCLE; CELL POPULATION; CELL RENEWAL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVATION; EXCISION REPAIR; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY;

ANIMALS; ANTIGENS, CD; APOPTOSIS; BRAIN NEOPLASMS; CELL LINE, TUMOR; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVATION; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; KARYOTYPING; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASTIC STEM CELLS; PEPTIDES; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES;

EID: 62549142665     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0409     Document Type: Article

References (32)

1. Hambardzumyan D, Squatrito M, Carbajal E, Holland EC. Glioma formation, cancer stem cells, and Akt signaling. Stem Cell Rev 2008;4:203-10.
2. Eramo A, Ricci-Vitiani L, Zeuner A, et al. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 2006;7:1238-41.
3. Murat A, Migliavacca E. Gorlia T, et al. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 2008;26:3015-24.
4. Jin F, Zhao L, Zhao HY, et al. Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes. Neuroscience 2008;154:541 -50.
5. Kang MK, Kang SK. Pharmacologic blockade of chloride channel synergistically enhances apoptosis of chemotherapeutic drug-resistant cancer stem cells. Biochem Biophys Res Commun 2008;373:539-44.
6. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-760.
7. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer 2006;6:425 - 436.
8. Beier D, Hau P, Proescholdt M, et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007;67:4010-5.
9. Gunther HS, Schmidt NO, Phillips HS, et al. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenorypic criteria. Oncogene 2008;27:2897-909.
10. Joo KM, Kim SY, Jin X, et al. Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas. Lab Invest 2008;88:808-15.
11. Bigner DD, Signer SH, Ponten J, et al. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J Neuropathol Exp Neurol 1981;40:201-29.
12. Bigner SH, Bullard DE, Pegram CN, Wikstrand CJ, Bigner DD. Relationship of in vitro morphologic and growth characteristics of established human glioma- derived cell lines to their tumorigenicity in athymic nude mice. J Neuropathol Exp Neurol 1981;40:390-409.
13. Bullard DE, Schold SC, Jr., Bigner SH, Bigner DD. Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines. J Neuropathol Exp Neurol 1981;40:410-27.
14. de Ridder LI, Laerum OD, Moørk SJ, Bigner DD. Invasiveness of human glioma cell lines in vitro: relation to tumorigenicity in athymic mice. Acta Neuropathol 1987;72:207-13.
15. 1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA 1998;95:15406-11.
16. Frosina G, Cappelli E, Ropolo M, Fortini P, Pascucci B, Dogliotti E. In vitro base excision repair assay using mammalian cell extracts. In: Henderson DS, editor. DNA repair protocols: mammalian systems. 2nd ed. Methods in molecular biology. Totowa (NJ): Humana Press; 2006. p. 377-96.
17. Srivastava N, Gochhait S, de Boer P, Bamezai RN. Role of H2AX in DNA damage response and human cancers. Mutat Res 2009;681:180-8.
18. Kinner A, Wu W, Staudt C, Iliakis G. γ-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res 2008;36:5678-94.
19. Zunino A, Degan P, Vigo T, Abbondandolo A. Hydrogen peroxide: effects on DNA, chromosomes, cell cycle and apoptosis induction in Fanconi's anemia cell lines. Mutagenesis 2001;16:283-8.
20. Enders GH. Expanded roles for Chkl in genome maintenance. J Biol Chem 2008;283:17749-52.
21. Antoni L, Sodha N, Collins I, Garrett MD. CHK2 kinase: cancer susceptibility and cancer therapy-two sides of the same coin? Nat Rev Cancer 2007;7:925-36.
22. Kondo T. Stem cell-like cancer cells in cancer cell lines. Cancer Biomark 2007;3:245-50.
23. Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science 2007:317:337.
24. Hill RP, Perris R. "Destemming" cancer stem cells. J Natl Cancer Inst 2007;99:1435 - 40.
25. Adams JM, Strasser A. Is tumor growth sustained by rare cancer stem cells or dominant clones? Cancer Res 2008;68:4018-21.
26. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005;5:275-84.
27. Svendsen CN, Caldwell MA, Ostenfeld T. Human neural stem cells: isolation, expansion and transplantation. Brain Pathol 1999;9:499-513.
28. Viaggi S, Abbondandolo A, Carbone M, et al. Uncommon cytogenetic findings in a case of splenic marginal zone lymphoma with aggressive clinical course. Cancer Genet Cytogenet 2004;148:133-6.
29. Ropolo M, Degan P, Foresta M, et al. Complementation of the oxidatively damaged DNA repair defect in Cockayne syndrome A and B cells by Escherichia coli formamidopyrimidine DNA glycosylase. Free Radic Biol Med 2007;42:1807-17.
30. Poggi A, Pellegatta F, Leone BE. Engagement of the leukocyte-associated Ig-like receptor-1 induces programmed cell death and prevents NF-κB nuclear translocation in human myeloid leukemias. Eur J Immunol 2000;30:2751-2758.
31. Glaab WE, Tindall KR. Mutation rate at the hprt locus in human cancer cell lines with specific mismatch repair-gene defects. Carcinogenesis 1997;18:1-8.
32. Tanaka M, Lai JS, Herr W. Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter. Cell 1992;68:755-67.